The new Gilead Sciences oral medication for HCV is headed into the stratosphere as predicted. It shot up today from last Friday’s close at $78.40 to $81.58. It’s already trading after hours at 4¢  above that at the time I write this. There’s a new click widget on the right (picture of a HCVirus) to check how insane the price per share is daily.